M. Violin

发表

Response to Antiretroviral Therapy in a Patient with an Uncommon Codon 69 Insertion in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase

C. Balotta, P. Bonfanti, S. Rusconi, 2000, Antimicrobial Agents and Chemotherapy.

Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure.

M. Moroni, M. Clementi, C. Balotta, 2000, Journal of acquired immune deficiency syndromes.

Evidence of Differential Selection of HIV-1 Variants Carrying Drug-Resistant Mutations in Seroconverters

M. Zazzi, P. Duca, C. Balotta, 2005, Antiviral therapy.

Homozygous Δ32 deletion of the CCR‐5 chemokine receptor gene in an HIV‐1‐infected patient

M. Moroni, M. Corbellino, M. Clerici, 1997 .

Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis.

M. Moroni, L. Papagno, R. Mazzucchelli, 1999, The Journal of infectious diseases.

Telbivudine in the Treatment of Chronic Hepatitis B: Experience in HIV Type-1-Infected Patients Naive for Antiretroviral Therapy

C. Balotta, M. Galli, L. Milazzo, 2009, Antiviral therapy.

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

Klaus Korn, Anne-Mieke Vandamme, Sabine Yerly, 2006, Journal of acquired immune deficiency syndromes.

Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failed.

Alessandro Cozzi-Lepri, A. d’Arminio Monforte, C. Perno, 2004, The Journal of infectious diseases.

Changing patterns in HIV‐1 non‐B clade prevalence and diversity in Italy over three decades *

M. Zazzi, C. Balotta, C. Riva, 2010, HIV Medicine.

Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children.

L. Papagno, G. Colucci, N. Principi, 1997, The Pediatric infectious disease journal.

Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection

M. Moroni, M. Clerici, C. Tincati, 2008, Antiviral therapy.

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

Klaus Korn, Anne-Mieke Vandamme, Sabine Yerly, 2005, The Journal of infectious diseases.

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Alessandro Cozzi-Lepri, M. Moroni, F. Chiodo, 2004, AIDS.

Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences.

M. Moroni, G. Ippolito, A. Vandamme, 2001 .

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

O. Pybus, A. Wensing, K. Korn, 2009, Retrovirology.

Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy.

P Pezzotti, A Cozzi-Lepri, A N Phillips, 2001, The Journal of infectious diseases.

Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation

G. Ippolito, C. Perno, C. Balotta, 2002, AIDS.

Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals.

M. Moroni, S. Antinori, M. Clementi, 1997, AIDS research and human retroviruses.

Prevalence of Transmitted Nucleoside Analogue-Resistant HIV-1 Strains and Pre-Existing Mutations in Pol Reverse Transcriptase and Protease Region: Outcome after Treatment in Recently Infected Individuals

M. Moroni, L. Papagno, R. Mazzucchelli, 2000, Antiviral therapy.

Fulminant myocarditis during HIV seroconversion: recovery with temporary left ventricular mechanical assistance.

F. Oliva, M. Frigerio, A. Brucato, 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.

Transmission of resistant HIV type 1 variants and epidemiological chains in Italian newly diagnosed individuals.

M. Gismondo, G. Zehender, C. Balotta, 2012, AIDS research and human retroviruses.

Inhibitors Multidrug Resistance to Other Protease Isolates Derived from Patients with Human Immunodeficiency Virus Type 1 Susceptibility to PNU-140690 (Tipranavir) of

M. Moroni, C. Balotta, M. Galli, 2014 .

Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors

M. Moroni, C. Balotta, M. Galli, 2000, Antimicrobial Agents and Chemotherapy.

Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy

M. Moroni, M. Clementi, C. Balotta, 2000, AIDS.

Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy.

M. Ciccozzi, C. Mussini, G. Rezza, 2010, AIDS research and human retroviruses.

Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy.

G. Filice, M. Zazzi, G. Casazza, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003–2012 decade in Italy

F. Ceccherini‐Silberstein, A. Antinori, M. Zazzi, 2014, BMC Infectious Diseases.

Increasing Prevalence of Non‐Clade B HIV‐1 Strains in Heterosexual Men and Women, as Monitored by Analysis of Reverse Transcriptase and Protease Sequences

M. Moroni, G. Ippolito, A. Vandamme, 2001, Journal of acquired immune deficiency syndromes.

Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals.

M. Moroni, R. Mazzucchelli, R. Bianchi, 2001, Journal of biological regulators and homeostatic agents.

Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001.

A. Monforte, P. Grossi, C. Perno, 2004, Journal of acquired immune deficiency syndromes.

Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men.

M. Zazzi, C. Balotta, M. Galli, 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Impact of Mutations Conferring Reduced Susceptibility to Lamivudine on the Response to Antiretroviral Therapy

M. Moroni, P. Narciso, G. Ippolito, 2000, Antiviral therapy.

Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient.

M. Moroni, M. Corbellino, M. Clerici, 1997, AIDS.

Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.

M. Moroni, G. Ippolito, A. Lazzarin, 2002, Journal of biological regulators and homeostatic agents.

Prevalence of transmitted drug resistance in Europe is largely influenced by the presence of non-B sequences: analysis of 1400 patients from 16 countries: the CATCH-Study

Soriano, A. Wensing, K. Korn, 2003 .

Transmitted virus with substitutions at position 215 and risk of virological failure in antiretroviral-naive patients starting highly active antiretroviral therapy

L. Minoli, C. Perno, C. Balotta, 2002 .

Changing patterns in HIV‐1 non‐B clade prevalence and diversity in Italy over three decades *

C. Balotta, F. Saladini, I. Vicenti, 2010, HIV medicine.